Cantor Fitzgerald reiterated coverage on OrganiGram Holdings with a new price target

12/8/21 5:14:59 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald reiterated coverage of OrganiGram Holdings with a rating of Overweight and set a new price target of $5.70 from $5.50 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OGI

Date	Price Target	Rating	Analyst
7/17/2024		Speculative Buy	Canaccord Genuity
4/15/2024		Neutral → Buy	Alliance Global Partners
1/13/2023		Hold → Buy	Stifel
1/12/2022		Hold → Speculative Buy	Canaccord Genuity
1/12/2022	$5.70 → $5.30	Overweight	Cantor Fitzgerald
12/8/2021	$5.50 → $5.70	Overweight	Cantor Fitzgerald